Subscribe to Updates
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated
Author: Editor
Premium Membership Required
You must be a Premium member to access this content.
Keurig Dr Pepper will acquire Dutch coffee and tea company JDE Peet’s in a roughly $18 billion deal that could give a boost to the U.S. giant’s struggling coffee business, the two companies said Monday.Shares of Keurig Dr Pepper fell roughly 8% in early trading, while shares of JDE Peet’s climbed 17%, on pace for its best day ever.The deal was first reported by the Wall Street Journal.Keurig Dr Pepper will pay JDE Peet’s shareholders 31.85 euros ($37.3) per share in cash, representing a 33% premium on the Dutch’s firm’s 90-day volume-weighted average stock price, which represents a total equity…
Premium Membership Required
You must be a Premium member to access this content.
Premium Membership Required
You must be a Premium member to access this content.
Premium Membership Required
You must be a Premium member to access this content.
Premium Membership Required
You must be a Premium member to access this content.
Premium Membership Required
You must be a Premium member to access this content.
Premium Membership Required
You must be a Premium member to access this content.
Premium Membership Required
You must be a Premium member to access this content.
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesEli Lilly’s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street.In a key late-stage trial, Eli Lilly’s pill, orforglipron, caused less weight loss and had higher side effects than what analysts were expecting. The pill’s efficacy also appeared to come in slightly below that of Novo Nordisk’s oral semaglutide for obesity, which showed strong data in a separate study.Shares of Eli Lilly fell…